Educational information, not medical advice — ask your doctor or midwife.
Track Sharbat Bazoori Motadil (Unani) with reminders and record whether it helped, in the app.
Sharbat Bazoori Motadil is a time-honored Unani compound syrup whose name roughly translates to 'balanced seed syrup' — 'bazoori' referring to seeds (bazar/bazr in Arabic-Persian) and 'motadil' meaning moderating or balancing. It is prepared by combining the expressed mucilages and oils of cooling seeds with anti-inflammatory botanicals in a sweet syrup base. The formula appears in classical Unani pharmacopoeias including the National Formulary of Unani Medicine (NFUM) published by the Government of India.
In Unani theory, urinary burning and inflammation arise from excess heat (Hararat) in the kidneys and bladder — a state this formula is designed to 'moderate.' In modern terms, the constituent seeds are rich in mucilaginous polysaccharides and phytosterols that coat and soothe irritated urinary epithelium, while white sandalwood provides well-documented antimicrobial and anti-inflammatory volatile compounds. The mild diuretic effect of the seed complex increases urine flow, helping flush irritants and bacteria from the lower urinary tract.
Traditionally prepared and dispensed as a thick, sweet syrup taken diluted in water. Manufactured forms are available from Indian Unani pharmaceutical companies (e.g., Hamdard, Rex, Dehlvi) in glass or plastic bottles of 200–500 mL.
Rooted in Graeco-Arabic (Tibb-e-Unani) medicine as transmitted through Ibn Sina's Canon of Medicine and later systematized in the Mughal-era Indian Unani tradition. Seed-based cooling formulas were a cornerstone of classical urinary therapy across Persian, Arab, and Indian medical systems. The formula was standardized and included in India's National Formulary of Unani Medicine, giving it official pharmacopoeial recognition.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.